Advances in hPSC expansion towards therapeutic entities: A review.

Tannenbaum SE, Reubinoff BE.

DOI: 10.1111/cpr.13247
Published: 2022-05-31
Container: Cell Prolif
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/cpr.13247,
  title = {Advances in hPSC expansion towards therapeutic entities: A review.},
  author = {Tannenbaum SE and  Reubinoff BE.},
  year = {2022},
  journal = {Cell Prolif},
  doi = {10.1111/cpr.13247},
  url = {https://doi.org/10.1111/cpr.13247}
}

RIS

TY  - JOUR
TI  - Advances in hPSC expansion towards therapeutic entities: A review.
AU  - Tannenbaum SE
AU  -  Reubinoff BE.
PY  - 2022
JO  - Cell Prolif
DO  - 10.1111/cpr.13247
UR  - https://doi.org/10.1111/cpr.13247
ER  -

APA

SE, T., & BE., R. (2022). Advances in hPSC expansion towards therapeutic entities: A review.. Cell Prolif. https://doi.org/10.1111/cpr.13247

Source records

europe-pmc · retrieved 2026-09-25T07:10:19.304Z